Current role
Biotechnology · Healthcare
CEO, Board Member
2025-07-01–present
Robert Charles Jahr
Board Member
Outlook Therapeutics, Inc. (OTLK)Equibles does not estimate personal net worth.
Get an email with a short summary when Outlook Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get OTLK alertsAbout Robert Charles Jahr
Robert Charles Jahr is recorded as CEO and Board Member at Outlook Therapeutics, Inc. (OTLK) since July 1, 2025. Outlook Therapeutics, Inc. reported in an 8-K filed July 1, 2025 that Robert Charles Jahr was appointed Class III director, effective July 1, 2025. Outlook Therapeutics, Inc. reported in an 8-K filed July 1, 2025 that Robert Charles Jahr was appointed President and Chief Executive Officer, effective July 1, 2025. Outlook Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Outlook Therapeutics, Inc. includes Robert C. Jahr (CEO and Board Member), Faisal G. Sukhtian (Chairman), Kevin Lundquist (CFO) and 7 others.
“On the Effective Date, the Board increased its size from nine to ten directors and elected Mr. Jahr to the Board to fill the resulting vacancy as a Class III director for a term expiring at the 2028 annual meeting of stockholders.”
“On June 28, 2025, the Board of Directors (the “Board”) of Outlook Therapeutics, Inc. (the “Company”) appointed Robert Charles Jahr as President and Chief Executive Officer of the Company and as a director, effective July 1, 2025 (the “Effective Date”).”
Affiliation history
-
Current
2025-07-01–present
-
Current
2025-07-01–present
Company network
Leadership on record at Outlook Therapeutics, Inc.
- Robert C. Jahr CEO, Board Member
- Faisal G. Sukhtian Chairman
- Kevin Lundquist CFO
- Lawrence Kenyon CFO, Board Member
- LawrenceA. Kenyon CFO
- Terry Dagnon COO
- Andong Huang Board Member
- Dr. Julia A. Haller Board Member
- Gerd Auffarth Board Member
- Julia A. Haller Board Member